1 |
Nieuwenhuijs-Moeke GJ, Pischke SE, Berger SP, et al. Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair[J]. J Clin Med, 2020,9(1):253.
|
2 |
Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age[J]. Nat Immunol, 2018,19(2):108-119.
|
3 |
Dugast AS, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion[J]. J Immunol, 2008,180(12):7898-7906.
|
4 |
Ji J, Zhuang Y, Lin Z, et al. Interferon-γ-induced myeloid-derived suppressor cells aggravate kidney ischemia-reperfusion injury by regulating innate immune cells[J]. Nephron, 2022,146(1):99-109.
|
5 |
Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat[J]. J Clin Invest, 1984,74(4):1156-1164.
|
6 |
Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age[J]. Nat Immunol, 2018,19(2):108-119.
|
7 |
Dugast AS, Haudebourg T, Coulon F, et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion[J]. J Immunol, 2008,180(12):7898-7906.
|
8 |
Tomić S, Joksimović B, Bekić M, et al. Prostaglanin-E2 potentiates the suppressive functions of human mononuclear myeloid-derived suppressor cells and increases their capacity to expand IL-10-producing regulatory T cell subsets[J]. Front Immunol, 2019,10:475.
|
9 |
Koehn BH, Apostolova P, Haverkamp JM, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells[J]. Blood, 2015, 126(13):1621-1628.
|
10 |
Medzhitov R. Inflammation 2010: new adventures of an old flame[J]. Cell, 2010, 140(6):771-776.
|
11 |
Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage[J]. Nat Rev Immunol, 2010,10(12):826-837.
|
12 |
Kurts C, Panzer U, Anders HJ, et al. The immune system and kidney disease: basic concepts and clinical implications[J]. Nat Rev Immunol, 2013,13(10):738-753.
|
13 |
Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice[J]. Crit Care, 2011,15(3):R153.
|
14 |
Rao J, Lu L, Zhai Y. T cells in organ ischemia reperfusion injury[J]. Curr Opin Organ Transplant, 2014,19(2):115-120.
|
15 |
Pegues MA, McWilliams IL, Szalai AJ. C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame?[J]. Am J Physiol Renal Physiol, 2016,311(1):F176-F181.
|
16 |
Ren JP, Wang L, Zhao J, et al. Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection[J]. Immunology, 2017,150(2):213-220.
|
17 |
Messmann JJ, Reisser T, Leithäuser F, et al. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity[J]. Blood, 2015,126(9):1138-1148.
|
18 |
Sinha P, Clements VK, Fulton AM, et al. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells[J]. Cancer Res, 2007,67(9):4507-4513.
|
19 |
Sinha P, Parker KH, Horn L, et al. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα[J]. Eur J Immunol, 2012,42(8):2052-2059.
|
20 |
黎贵芸,冯强,胡雄,等. COX-2/PGE2在肿瘤发生发展和重塑肿瘤微环境中的研究进展[J]. 中国肿瘤临床,2020,47(16):840-846.
|